STEPHANE COUNTS: Open Payments
NPI 1922356823 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,789 in 107 payments from 18 companies in 2025. Trend: 2023 $1,727 · 2024 $3,091 · 2025 $2,789
Food & beverage: $2,789
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 35 | $957 |
| ViiV Healthcare Company | 28 | $894 |
| Vanda Pharmaceuticals Inc. | 10 | $245 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| Napo Pharmaceuticals Inc | 4 | $95 |
| EMD Serono, Inc. | 5 | $95 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| ABBVIE INC. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $39 |
Products named: APRETUDE, CABENUVA, HETLIOZ, FANAPT, INGREZZA, Mytesi, DOVATO, PIFELTRO.
Industry payments across MO — which companies pay providers there.
